{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:46:23Z","timestamp":1786373183160,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>The impact of AKI on adverse drug events and therapeutic failures and the medication errors leading to these events have not been well described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>A single-center observational study of 396 hospitalized patients with a minimum 0.5 mg\/dl change in serum creatinine who were prescribed a nephrotoxic or renally eliminated medication was conducted. The population was stratified into two groups by the direction of their initial serum creatinine change: AKI and AKI recovery. Adverse drug events, potential adverse drug events, therapeutic failures, and potential therapeutic failures for 148 drugs and 46 outcomes were retrospectively measured. Events were classified for preventability and severity by expert adjudication. Multivariable analysis identified medication classes predisposing AKI patients to adverse drug events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-three percent of patients experienced a potential adverse drug event, adverse drug event, therapeutic failure, or potential therapeutic failure; 66% of study events were preventable. Failure to adjust for kidney function (63%) and use of nephrotoxic medications during AKI (28%) were the most common potential adverse drug events. Worsening AKI and hypotension were the most common preventable adverse drug events. Most adverse drug events were considered serious (63%) or life-threatening (31%), with one fatal adverse drug event. Among AKI patients, administration of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers, antibiotics, and antithrombotics was most strongly associated with the development of an adverse drug event or potential adverse drug event.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adverse drug events and potential therapeutic failures are common and frequently severe in patients with AKI exposed to nephrotoxic or renally eliminated medications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.11921112","type":"journal-article","created":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T00:56:31Z","timestamp":1364518591000},"page":"1070-1078","source":"Crossref","is-referenced-by-count":69,"title":["Adverse Drug Events during AKI and Its Recovery"],"prefix":"10.2215","volume":"8","author":[{"given":"Zachary L.","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison B.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Matheny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Bhave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraja B.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Siew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Danciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Alp","family":"Ikizler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin B.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh F.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20230811","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","article-title":"Hospital-acquired renal insufficiency.","volume":"39","author":"Nash","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R2-5-20230811","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1097\/01.ASN.0000130340.93930.DD","article-title":"Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study.","volume":"15","author":"Lassnigg","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R3-5-20230811","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.","volume":"16","author":"Chertow","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R4-5-20230811","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1001\/jama.286.22.2839","article-title":"Guided medication dosing for inpatients with renal insufficiency.","volume":"286","author":"Chertow","year":"2001","journal-title":"JAMA"},{"key":"R5-5-20230811","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/intqhc\/mzg046","article-title":"Medication misuse in hospitalized patients with renal impairment.","volume":"15","author":"Salomon","year":"2003","journal-title":"Int J Qual Health Care"},{"key":"R6-5-20230811","first-page":"497","article-title":"Inappropriate drug dosage adjustments in patients with renal impairment.","volume":"22","author":"Markota","year":"2009","journal-title":"J Nephrol"},{"key":"R7-5-20230811","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1197\/jamia.M2805","article-title":"Effect of alerts for drug dosage adjustment in inpatients with renal insufficiency.","volume":"16","author":"Sellier","year":"2009","journal-title":"J Am Med Inform Assoc"},{"key":"R8-5-20230811","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11606-007-0336-8","article-title":"Overdose rate of drugs requiring renal dose adjustment: Data analysis of 4 years prescriptions at a tertiary teaching hospital.","volume":"23","author":"Sheen","year":"2008","journal-title":"J Gen Intern Med"},{"key":"R9-5-20230811","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jama.1997.03540280045032","article-title":"The costs of adverse drug events in hospitalized patients.","volume":"277","author":"Bates","year":"1997","journal-title":"JAMA"},{"key":"R10-5-20230811","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","article-title":"Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality.","volume":"277","author":"Classen","year":"1997","journal-title":"JAMA"},{"key":"R11-5-20230811","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ki.2009.353","article-title":"Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney.","volume":"76","author":"Hug","year":"2009","journal-title":"Kidney Int"},{"key":"R12-5-20230811","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1001\/jama.2012.4315","article-title":"Kidney attack.","volume":"307","author":"Kellum","year":"2012","journal-title":"JAMA"},{"key":"R13-5-20230811","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jbi.2005.08.009","article-title":"The anatomy of decision support during inpatient care provider order entry (CPOE): Empirical observations from a decade of CPOE experience at Vanderbilt.","volume":"38","author":"Miller","year":"2005","journal-title":"J Biomed Inform"},{"key":"R14-5-20230811","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/archinte.1994.00420130107014","article-title":"Effect of computer-based alerts on the treatment and outcomes of hospitalized patients.","volume":"154","author":"Rind","year":"1994","journal-title":"Arch Intern Med"},{"key":"R15-5-20230811","first-page":"1093","article-title":"Improving aminoglycoside dosing through computerized clinical decision support and pharmacy therapeutic monitoring systems.","volume":"2008","author":"Phillips","year":"2008","journal-title":"AMIA Annu Symp Proc"},{"key":"R16-5-20230811","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4338\/ACI-2012-03-RA-0009","article-title":"Real-time pharmacy surveillance and clinical decision support to reduce adverse drug events in acute kidney injury: A randomized, controlled trial.","volume":"3","author":"McCoy","year":"2012","journal-title":"Appl Clin Inform"},{"key":"R17-5-20230811","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1053\/j.ajkd.2010.05.024","article-title":"A computerized provider order entry intervention for medication safety during acute kidney injury: A quality improvement report.","volume":"56","author":"McCoy","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R18-5-20230811","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/amiajnl-2011-000185","article-title":"A framework for evaluating the appropriateness of clinical decision support alerts and responses.","volume":"19","author":"McCoy","year":"2012","journal-title":"J Am Inform Assoc"},{"key":"R19-5-20230811","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury.","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"R20-5-20230811","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1097\/CCM.0b013e3182281f1b","article-title":"Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteria.","volume":"39","author":"Mandelbaum","year":"2011","journal-title":"Crit Care Med"},{"key":"R23-5-20230811","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199102073240605","article-title":"The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II.","volume":"324","author":"Leape","year":"1991","journal-title":"N Engl J Med"},{"key":"R24-5-20230811","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jama.1995.03530010043033","article-title":"Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.","volume":"274","author":"Bates","year":"1995","journal-title":"JAMA"},{"key":"R25-5-20230811","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/qshc.2004.010611","article-title":"Adverse drug events and medication errors: Detection and classification methods.","volume":"13","author":"Morimoto","year":"2004","journal-title":"Qual Saf Health Care"},{"key":"R26-5-20230811","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s11606-008-0687-9","article-title":"Classifying and predicting errors of inpatient medication reconciliation.","volume":"23","author":"Pippins","year":"2008","journal-title":"J Gen Intern Med"},{"key":"R27-5-20230811","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/jamia.1998.0050305","article-title":"Identifying adverse drug events: Development of a computer-based monitor and comparison with chart review and stimulated voluntary report.","volume":"5","author":"Jha","year":"1998","journal-title":"J Am Med Inform Assoc"},{"key":"R28-5-20230811","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1592\/phco.29.11.1275","article-title":"Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.","volume":"29","author":"Rybak","year":"2009","journal-title":"Pharmacotherapy"},{"key":"R30-5-20230811","first-page":"674","article-title":"Implementation of a once-daily aminoglycoside program in a large community-teaching hospital.","volume":"30","author":"Nicolau","year":"1995","journal-title":"Hosp Pharm"},{"key":"R31-5-20230811","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1001\/archinte.159.21.2553","article-title":"Patient risk factors for adverse drug events in hospitalized patients.","volume":"159","author":"Bates","year":"1999","journal-title":"Arch Intern Med"},{"key":"R32-5-20230811","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: A clinician\u2019s guide to terminology, documentation, and reporting.","volume":"140","author":"Nebeker","year":"2004","journal-title":"Ann Intern Med"},{"key":"R33-5-20230811","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1345\/aph.1E642","article-title":"Risk factors for adverse drug events: A 10-year analysis.","volume":"39","author":"Evans","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R34-5-20230811","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jama.1997.03540280050033","article-title":"Factors related to errors in medication prescribing.","volume":"277","author":"Lesar","year":"1997","journal-title":"JAMA"},{"key":"R35-5-20230811","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJM199102073240604","article-title":"Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I.","volume":"324","author":"Brennan","year":"1991","journal-title":"N Engl J Med"},{"key":"R36-5-20230811","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/01.CCM.0000171609.91035.BD","article-title":"The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care.","volume":"33","author":"Rothschild","year":"2005","journal-title":"Crit Care Med"},{"key":"R37-5-20230811","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/00003246-199708000-00014","article-title":"Preventable adverse drug events in hospitalized patients: A comparative study of intensive care and general care units.","volume":"25","author":"Cullen","year":"1997","journal-title":"Crit Care Med"},{"key":"R38-5-20230811","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/jama.1990.03440170051035","article-title":"Medication prescribing errors in a teaching hospital.","volume":"263","author":"Lesar","year":"1990","journal-title":"JAMA"},{"key":"R39-5-20230811","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1097\/CCM.0b013e3181dd8364","article-title":"Adverse drug events in intensive care units: Risk factors, impact, and the role of team care.","volume":"38","author":"Kane-Gill","year":"2010","journal-title":"Crit Care Med"},{"key":"R40-5-20230811","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00228-010-0987-y","article-title":"Adverse drug events in an intensive care unit of a university hospital.","volume":"67","author":"Reis","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"R41-5-20230811","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1097\/CCM.0b013e3181de0c60","article-title":"Drug-induced acute kidney injury in the critically ill adult: Recognition and prevention strategies.","volume":"38","author":"Bentley","year":"2010","journal-title":"Crit Care Med"},{"key":"R42-5-20230811","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.294.7.813","article-title":"Acute renal failure in critically ill patients: A multinational, multicenter study.","volume":"294","author":"Uchino","year":"2005","journal-title":"JAMA"},{"key":"R43-5-20230811","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1523-1755.2004.00927.x","article-title":"Spectrum of acute renal failure in the intensive care unit: The PICARD experience.","volume":"66","author":"Mehta","year":"2004","journal-title":"Kidney Int"},{"key":"R44-5-20230811","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archinternmed.2010.514","article-title":"The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death.","volume":"171","author":"Ishani","year":"2011","journal-title":"Arch Intern Med"},{"key":"R45-5-20230811","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1053\/ajkd.2002.34505","article-title":"Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies.","volume":"40","author":"Morgera","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R46-5-20230811","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2011.50","article-title":"Computerized decision support systems: Improving patient safety in nephrology.","volume":"7","author":"Chang","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"R47-5-20230811","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/cc3983","article-title":"Impact of computerized physician order entry on medication prescription errors in the intensive care unit: A controlled cross-sectional trial.","volume":"10","author":"Colpaert","year":"2006","journal-title":"Crit Care"},{"key":"R48-5-20230811","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/archinte.165.10.1111","article-title":"High rates of adverse drug events in a highly computerized hospital.","volume":"165","author":"Nebeker","year":"2005","journal-title":"Arch Intern Med"},{"key":"R49-5-20230811","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"R50-5-20230811","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9343(62)90183-3","article-title":"A clinical appraisal of the plasma concentration and endogenous clearance of creatinine.","volume":"32","author":"Doolan","year":"1962","journal-title":"Am J Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201307000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:43:16Z","timestamp":1786369396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201307000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.11921112","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}